Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The complement system in type 1 (insulin-dependent) diabetes.

J A Charlesworth1, V Timmermans, J Golding

  • 1Department of Medicine, Prince Henry Hospital, Sydney, Australia.

Diabetologia
|June 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors associated with poorer experiences of end-of-life care and challenges in early bereavement: Results of a national online survey of people bereaved during the COVID-19 pandemic.

Palliative medicine·2022
Same author

The First Case Report of Schnitzler Syndrome Presenting with Eye Pain.

Ocular immunology and inflammation·2019
Same author

The natural history of acute Q fever: a prospective Australian cohort.

QJM : monthly journal of the Association of Physicians·2016
Same author

Tracing the fate of limbal epithelial progenitor cells in the murine cornea.

Stem cells (Dayton, Ohio)·2014
Same author

Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Human limbal epithelial progenitor cells express αvβ5-integrin and the interferon-inducible chemokine CXCL10/IP-10.

Stem cell research·2013
Same journal

Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivity.

Diabetologia·2026
Same journal

Baseline and longitudinal joint associations of alcohol consumption and obesity with diabetes risk: evaluating multiplicative and additive interactions.

Diabetologia·2026
Same journal

GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study.

Diabetologia·2026
Same journal

Correction: Analysis of glycaemic control with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.

Diabetologia·2026
Same journal

History of infertility, risk of type 2 diabetes and HbA<sub>1c</sub> levels in the Nurses' Health Study II.

Diabetologia·2026
Same journal

Delayed maturation of the milk microbiome in women with type 1 diabetes.

Diabetologia·2026
See all related articles

Early complement proteins like C1q, C4, and C3 are significantly reduced in individuals with Type 1 diabetes, regardless of disease duration or complications. This reduction is linked to decreased synthesis of these proteins.

Area of Science:

  • Immunology
  • Endocrinology
  • Biochemistry

Background:

  • Type 1 diabetes is an autoimmune disease affecting insulin production.
  • The complement system plays a crucial role in immune responses and inflammation.
  • Alterations in complement protein levels may be associated with Type 1 diabetes pathogenesis.

Purpose of the Study:

  • To investigate complement protein levels in patients with Type 1 diabetes.
  • To compare complement protein levels across different disease durations and complication statuses.
  • To explore the role of complement component 4 (C4) allotypes and metabolic factors in observed abnormalities.

Main Methods:

  • Measurement of complement proteins (C1q, C4, C3, etc.) and inhibitors in patient groups and controls.

Related Experiment Videos

  • Analysis of C4 allotypes to identify null alleles.
  • Radiolabeled turnover studies of C3 and C4 in a subset of patients.

    • Main Results:

    • Significantly reduced levels of C1q, C4, and C3 were observed in all Type 1 diabetes patient groups compared to controls.
    • C4 levels were also reduced in healthy first-degree relatives.
    • Reduced synthesis of C3 and C4 was identified as a primary cause for low concentrations, with some cases of C4 hypercatabolism.

    Conclusions:

    • Early complement proteins are consistently reduced in Type 1 diabetes.
    • These reductions are independent of disease duration and the presence of complications.
    • Decreased protein synthesis is a key factor contributing to complement abnormalities in Type 1 diabetes.